Schedule 13G ownership disclosure

Sunesis Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 867328700

Event date: 2018-06-13

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,000,001
Percent of class
1.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-18-037855
Form type
SC 13G/A
Filer
RA CAPITAL MANAGEMENT, L.P.
CIK
CIK 1346824
Filed
Jul 10, 2018
Reporting period
Jun 13, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub